PURPOSE:: An overview of existing good practices related to translating evidence to policy has been done by a multidisciplinary group of ISPOR and non-ISPOR members from all regions of the world and undergone two rounds of review including a public review. Emphasis was mainly on approaches to inform population-based purchasing, reimbursement, and formulary decisions on pharmaceuticals and medical devices while not excluding clinical practice guideline or pathway development. Next step is to identify areas in need of guidance and good research practice documents, and discuss approaches of how to address them. The workshop offers an opportunity to discuss where there is most need to improve the situation taking a perspective of those producing HTA, e.g., national and regional HTA agencies. DESCRIPTION:: Informing population-based health care decisions using evidence after regulatory approval is a fast-growing policy –- and scientific –- field. It is necessary to identify good practices in this field to advance the science of informing decision making and promote appropriate capacity building and education. Workshop participants will be presented with examples of best practices and guidance identified through a scoping review. The workshop will discuss where good practices have not yet been identified, and how the situation could be improved at European and global scale. Presented by the ISPOR Health Technology Assessment (HTA) Council Working Group